Lawrence Salvo
Nessuna posizione attualmente
Profilo
Lawrence Salvo is the founder of NuGenerex Diagnostics LLC.
Prior to founding NuGenerex Diagnostics LLC, he worked as the Director & Executive VP-Diagnostics at Generex Biotechnology Corp.
He completed his undergraduate degree at St. Vincent De Paul Seminary.
Precedenti posizioni note di Lawrence Salvo
| Società | Posizione | Fine |
|---|---|---|
NuGenerex Diagnostics LLC
 NuGenerex Diagnostics LLC Medical SpecialtiesHealth Technology NuGenerex Diagnostics LLC manufactures and distributes diagnostic testing devices. Its product includes devices for human immunodeficiency virus (HIV), tuberculosis, malaria, and syphilis. The firm also offers Rapid 1-2-3 Hema Dipstick formast tests for hepatis B and C. The company was founded in December 1, 2000 and is headquartered in Miramar, FL. | Amministratore Delegato | 01/03/2017 |
| GENEREX BIOTECHNOLOGY CORPORATION | Direttore/Membro del Consiglio | - |
Formazione di Lawrence Salvo
| St. Vincent De Paul Seminary | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Generex Biotechnology Corp.
 Generex Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. It builds new kind of healthcare company, which provides support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. The company was founded by Rose C. Perri on September 4, 1997 and is headquartered in Miramar, FL. | Health Technology |
NuGenerex Diagnostics LLC
NuGenerex Diagnostics LLC Medical SpecialtiesHealth Technology NuGenerex Diagnostics LLC manufactures and distributes diagnostic testing devices. Its product includes devices for human immunodeficiency virus (HIV), tuberculosis, malaria, and syphilis. The firm also offers Rapid 1-2-3 Hema Dipstick formast tests for hepatis B and C. The company was founded in December 1, 2000 and is headquartered in Miramar, FL. | Health Technology |
- Borsa valori
- Insiders
- Lawrence Salvo
